FDA loves replicate bears? [🇷 for BE/BA]

posted by yjlee168 Homepage – Kaohsiung, Taiwan, 2009-04-23 10:08 (5919 d 05:50 ago) – Posting: # 3587
Views: 69,327

Dear D. Labes,

Thank you for your message. I find that currently bear's model dealing with replicate ABE data is equivalent to SAS Proc MIXED as the follows:
PROC MIXED;
CLASSES SEQ SUBJ PER TRT;
MODEL Y = SEQ PER TRT/ DDFM=SATTERTH;
RANDOM SUB=SUBJ G;
REPEATED/GRP=TRT SUB=SUBJ;
ESTIMATE 'T vs. R' TRT 1 -1/CL ALPHA=0.1;

(Ref.: Jones, B and Kenward MG. Design and Analysis of Cross-Over Trials, 2nd ed., Chapman & Hall/CRC, 2003). If using TYPE setting, either FA0(2) or CSH as recommended by FDA, we will not get the exactly same 90%CIs from running bear using lme(). I guess we need to find out how to comply with here.

All the best,
-- Yung-jin Lee
bear v2.9.2:- created by Hsin-ya Lee & Yung-jin Lee
Kaohsiung, Taiwan https://www.pkpd168.com/bear
Download link (updated) -> here

Complete thread:

UA Flag
Activity
 Admin contact
23,428 posts in 4,929 threads, 1,682 registered users;
56 visitors (0 registered, 56 guests [including 17 identified bots]).
Forum time: 15:59 CEST (Europe/Vienna)

No matter what side of the argument you are on,
you always find people on your side
that you wish were on the other.    Thomas Berger

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5